Literature DB >> 9271430

A role for the ETS domain transcription factor PEA3 in myogenic differentiation.

J M Taylor1, E E Dupont-Versteegden, J D Davies, J A Hassell, J D Houlé, C M Gurley, C A Peterson.   

Abstract

Activation of adult myoblasts called satellite cells during muscle degeneration is an important aspect of muscle regeneration. Satellite cells are believed to be the only myogenic stem cells in adult skeletal muscle and the source of regenerating muscle fibers. Upon activation, satellite cells proliferate, migrate to the site of degeneration, and become competent to fuse and differentiate. We show here that the transcription factor polyomavirus enhancer activator 3 (PEA3) is expressed in adult myoblasts in vitro when they are proliferative and during the early stages of differentiation. Overexpression of PEA3 accelerates differentiation, whereas blocking of PEA3 function delays myoblast fusion. PEA3 activates gene expression following binding to the ets motif most efficiently in conjunction with the transcription factor myocyte enhancer factor 2 (MEF2). In vivo, PEA3 is expressed in satellite cells only after muscle degeneration. Taken together, these results suggest that PEA3 is an important regulator of activated satellite cell function.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9271430      PMCID: PMC232403          DOI: 10.1128/MCB.17.9.5550

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  57 in total

1.  Migration of myoblasts across basal lamina during skeletal muscle development.

Authors:  S M Hughes; H M Blau
Journal:  Nature       Date:  1990-05-24       Impact factor: 49.962

2.  Negative control of the helix-loop-helix family of myogenic regulators in the NFB mutant.

Authors:  C A Peterson; H Gordon; Z W Hall; B M Paterson; H M Blau
Journal:  Cell       Date:  1990-08-10       Impact factor: 41.582

3.  In situ detection of sequence-specific DNA binding activity specified by a recombinant bacteriophage.

Authors:  C R Vinson; K L LaMarco; P F Johnson; W H Landschulz; S L McKnight
Journal:  Genes Dev       Date:  1988-07       Impact factor: 11.361

4.  Regulatory role of MEF2D in serum induction of the c-jun promoter.

Authors:  T H Han; R Prywes
Journal:  Mol Cell Biol       Date:  1995-06       Impact factor: 4.272

5.  Regulation of the myoblast-specific expression of the human beta-enolase gene.

Authors:  J M Taylor; J D Davies; C A Peterson
Journal:  J Biol Chem       Date:  1995-02-10       Impact factor: 5.157

Review 6.  Transcriptional regulation by extracellular signals: mechanisms and specificity.

Authors:  C S Hill; R Treisman
Journal:  Cell       Date:  1995-01-27       Impact factor: 41.582

Review 7.  The muscle satellite cell: a review.

Authors:  D R Campion
Journal:  Int Rev Cytol       Date:  1984

8.  Myogenin and MEF2 function synergistically to activate the MRF4 promoter during myogenesis.

Authors:  P S Naidu; D C Ludolph; R Q To; T J Hinterberger; S F Konieczny
Journal:  Mol Cell Biol       Date:  1995-05       Impact factor: 4.272

9.  The collagenase gene promoter contains a TPA and oncogene-responsive unit encompassing the PEA3 and AP-1 binding sites.

Authors:  A Gutman; B Wasylyk
Journal:  EMBO J       Date:  1990-07       Impact factor: 11.598

10.  PEA3 is a nuclear target for transcription activation by non-nuclear oncogenes.

Authors:  C Wasylyk; P Flores; A Gutman; B Wasylyk
Journal:  EMBO J       Date:  1989-11       Impact factor: 11.598

View more
  10 in total

1.  Synergistic action of GA-binding protein and glucocorticoid receptor in transcription from the mouse mammary tumor virus promoter.

Authors:  K Aurrekoetxea-Hernández; E Buetti
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

2.  Cell death-resistance of differentiated myotubes is associated with enhanced anti-apoptotic mechanisms compared to myoblasts.

Authors:  Rijin Xiao; Amy L Ferry; Esther E Dupont-Versteegden
Journal:  Apoptosis       Date:  2011-03       Impact factor: 4.677

3.  Enhanced survival of skeletal muscle myoblasts in response to overexpression of cold shock protein RBM3.

Authors:  Amy L Ferry; Peter W Vanderklish; Esther E Dupont-Versteegden
Journal:  Am J Physiol Cell Physiol       Date:  2011-05-18       Impact factor: 4.249

4.  Tissue-restricted expression of the cardiac alpha-myosin heavy chain gene is controlled by a downstream repressor element containing a palindrome of two ets-binding sites.

Authors:  M Gupta; R Zak; T A Libermann; M P Gupta
Journal:  Mol Cell Biol       Date:  1998-12       Impact factor: 4.272

5.  Reduced differentiation potential of primary MyoD-/- myogenic cells derived from adult skeletal muscle.

Authors:  L A Sabourin; A Girgis-Gabardo; P Seale; A Asakura; M A Rudnicki
Journal:  J Cell Biol       Date:  1999-02-22       Impact factor: 10.539

6.  Systematic discovery and characterization of regulatory motifs in ENCODE TF binding experiments.

Authors:  Pouya Kheradpour; Manolis Kellis
Journal:  Nucleic Acids Res       Date:  2013-12-13       Impact factor: 16.971

7.  Integrated Analysis of the ETS Family in Melanoma Reveals a Regulatory Role of ETV7 in the Immune Microenvironment.

Authors:  Hui Qu; Hui Zhao; Xi Zhang; Yang Liu; Feng Li; Liyan Sun; Zewen Song
Journal:  Front Immunol       Date:  2020-12-23       Impact factor: 7.561

8.  Quercetin induces pannexin 1 expression via an alternative transcript with a translationally active 5' leader in rhabdomyosarcoma.

Authors:  Xiao Xiang; Huy-Dung Hoang; Victoria H Gilchrist; Stéphanie Langlois; Tommy Alain; Kyle N Cowan
Journal:  Oncogenesis       Date:  2022-02-22       Impact factor: 6.524

9.  Comprehensive Analysis Identified ETV7 as a Potential Prognostic Biomarker in Bladder Cancer.

Authors:  Haimeng Li; Yibo Zhang; Shangyong Zheng
Journal:  Biomed Res Int       Date:  2021-12-09       Impact factor: 3.411

10.  Pea3 transcription factor promotes neurite outgrowth.

Authors:  Basak Kandemir; Berrak Caglayan; Barbara Hausott; Burcu Erdogan; Ugur Dag; Ozlem Demir; Melis S Sogut; Lars Klimaschewski; Isil A Kurnaz
Journal:  Front Mol Neurosci       Date:  2014-06-26       Impact factor: 5.639

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.